ArticleMedicine2025
Different associations between dietary or supplemental vitamin C intake and HPV infection in American women: A cross-sectional study.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Evidence regarding the relationship between dietary or supplemental vitamin C intake and human papillomavirus infection is limited. Therefore, this study aimed to evaluate if dietary and/or supplemental vitamin C intake is independently associated with human papillomavirus (HPV) infection and compare them. The analysis utilized data extracted from the National Health and Nutrition Examination Survey spanning from 2007 to 2016. The study cohort comprised 950 women within the age range of 18 to 59 years. The associations between dietary and supplemental vitamin C intake and cervicovaginal human papillomavirus infection were estimated using weighted logistic regression, interaction analyses, and subgroup analyses based on complex multistage sampling. Adjusted binary logistic regression revealed that supplemental vitamin C intake was negatively associated with the risk of HPV (adjusted odds ratio [AOR] 0.94, 95% confidence interval [CI] 0.89-0.99) and high-risk human papillomavirus infection (AOR = 0.76, 95% CI = 0.55-0.99). However, we did not find an association between dietary vitamin C and human papillomavirus infection (AOR = 1.18, CI = 0.96-1.45). Subgroup analyses indicated that supplemental vitamin C was only negatively associated with human papillomavirus infection in women older than 25 years (P = .03) and was more strongly associated with HPV infection in those who did not receive HPV vaccination (Pinteraction = 0.03). The results from a nationally representative sample from the United States supported that the protective effect of vitamin C against human papillomavirus infection was driven mainly by supplemental vitamin C rather than dietary vitamin C.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.